Indian healthcare providers now face a changing landscape in the rehydration market. Recently, new FSSAI ORS Regulations significantly reduced the visibility of misleading sugary drinks.
Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s best-selling medication.Mounjaro generated $8.7 billion for
Mumbai (Maharashtra): India’s protein supplements market reached approximately USD $912.9 million in 2025, according to IMARC Group, and is projected to grow to USD $1,578.1
The Indian government is in no hurry to ac-cept the Punjab government’s demand to de-notify hybrid rice varieties seeds for the State. This follows the
NEW DELHI: Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works
After months of rapid growth that reshaped the Indian pharmaceutical market’s leader board, Mounjaro’s (tirzepatide) dream run hit a speed bump in March when Eli
Experts feel that absence of such a mechanism creates structural disadvantage for manufacturers.Ahead of the next GST Council meeting, industry leaders are pushing for a